PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 24, 2026Communications Biology3 citationsOpen Access

NLRP10 engages oxidized DNA through a Schiff-base mechanism and dissociates from NLRP3 upon inflammasome activation

View Full Paper
JCJulia Elise CabralUniversity of California, IrvineALAngela LacknerUniversity of California, IrvineWJWenjin JiangUniversity of California, Irvine

Key Points

  • This research aims to understand how NLRP10 interacts with oxidized mitochondrial DNA and its role in inflammasome activation.
  • Examined the interaction between NLRP3 and NLRP10 during inflammasome activation
  • Analyzed the role of oxidized D-loop mtDNA in the cytosol
  • Investigated the mechanism of NLRP10-mediated DNA cleavage via a Schiff base intermediate
  • Assessed the impact of small molecule inhibitors on glycosylases
  • NLRP3 is involved in the release of D-loop mtDNA into the cytosol
  • NLRP10 demonstrates a specific interaction with oxidized DNA linked to inflammasome activation
  • Small molecules inhibiting glycosylases reduce NLRP10's cleavage activity on oxidized DNA
  • Findings suggest a potential therapeutic strategy targeting NLRP10 interactions in inflammatory diseases

Abstract

Abstract Mitochondrial DNA release into the cytosol is a critical event in innate immune activation, often acting as a damage-associated molecular pattern (DAMP) that triggers inflammasome assembly. Here, we demonstrate that NLRP3 is involved in the release of D-loop mtDNA into the cytosol. We further show that NLRP3 interacts with NLRP10. NLRP10-mediated oxidized DNA cleavage involves a Schiff base intermediate and is inhibited by small molecules known to inhibit glycosylases. These findings support a model where NLRP10 interaction with oxidized DNA may contribute to long-term senescence secretory phenotype and modulate inflammasome activation. Our study highlights a novel mechanism by which NLRP10 can respond to mitochondrial stress signals to influence innate immunity and suggests therapeutic potential for targeting these interactions in inflammatory diseases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cabral et al. (2026) studied this question.

synapsesocial.com/papers/6974610cbb9d90c67120ae23https://doi.org/10.1038/s42003-025-09501-x
Ask AI
Helpful
Bookmark
Share
View Full Paper